Cargando…

Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer

Background: Endometrial cancer (EC) is a major gynecologic adenocarcinoma that arises from the endometrium. While the incidence of EC is on the rise worldwide, survivorship and clinical advancement have considerably lagged compared to other cancers. Given the sensitive nature of the endometrium and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Caifeng, Tran, Davis A., Fu, Melinda Z., Chen, Wei, Fu, Sidney W., Li, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052878/ https://www.ncbi.nlm.nih.gov/pubmed/32194781 http://dx.doi.org/10.7150/jca.41943

Ejemplares similares

Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
por: Kreizman-Shefer, Hila, et al.
Publicado: (2014)

The expression of stanniocalcin-1, estrogen receptor and progesterone receptor in endometrioid endometrial cancer
por: Erkılınç, Gamze, et al.
Publicado: (2023)

Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?
por: Shen, Fang, et al.
Publicado: (2016)

Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma
por: de Souza, Ana Amélia, et al.
Publicado: (2019)

Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer
por: Zhao, Shen, et al.
Publicado: (2019)

Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer
por: Liu, Xi-Yu, et al.
Publicado: (2018)

Expression of Estrogen Receptors (ER), Progesterone Receptors (PR) and HER-2/neu receptors in Endometrial Carcinoma and their associations with histological types, grades and stages of the tumor
por: Waqar, Samina, et al.
Publicado: (2018)

Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer
por: Li, Ning, et al.
Publicado: (2022)

Leptin receptor expression during the progression of endometrial carcinoma is correlated with estrogen and progesterone receptors
por: Méndez-López, Luis Fernando, et al.
Publicado: (2016)

Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer
por: Ko, Eunkyung, et al.
Publicado: (2010)

The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas
por: Gul, Aylin Ege, et al.
Publicado: (2010)

Estrogen and Progesterone Receptors in Endometrium in Women with Unexplained Infertility
por: Godinjak, Zulfo, et al.
Publicado: (2014)

Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer
por: Yang, Shujie, et al.
Publicado: (2014)

Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
por: Yu, Ke-Da, et al.
Publicado: (2015)

Androgen receptor and its correlation with estrogen and progesterone receptors, aimed for identification of cases for future anti-androgen therapy in endometrial cancers
por: Moatamed, Neda A., et al.
Publicado: (2023)

Researches on the Correlation Between Estrogen and Progesterone Receptors Expression and Disease-Free Survival of Endometrial Cancer
por: Ren, Siling, et al.
Publicado: (2020)

Relationship between the expression of oestrogen receptor and progesterone receptor and (18)F-FDG uptake in endometrial cancer
por: Wu, Chunhua, et al.
Publicado: (2020)

Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
por: Chan, Melissa, et al.
Publicado: (2015)

Progesterone receptor modulates estrogen receptor-α action in breast cancer
por: Mohammed, Hisham, et al.
Publicado: (2015)

Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer
por: Fan, Ying, et al.
Publicado: (2015)

Estrogen Receptor Mutations and Changes in Estrogen Receptor and Progesterone Receptor Protein Expression in Metastatic or Recurrent Breast Cancer
por: Umekita, Yoshihisa, et al.
Publicado: (1998)

Endometrial changes in estrogen and progesterone receptor expression during implantation in an oocyte donation program
por: Klonos, Eleftherios, et al.
Publicado: (2020)

Endometrial Progesterone and Estrogen Receptors in Relation to Hormonal Levels in Women with Unexplained Recurrent Miscarriage
por: Gomaa, Ihab Adel, et al.
Publicado: (2023)

Genistein induces long-term expression of progesterone receptor regardless of estrogen receptor status and improves the prognosis of endometrial cancer patients
por: Yoriki, Kaori, et al.
Publicado: (2022)

Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study
por: Wei, Jin-Li, et al.
Publicado: (2018)

RIME proteomics of estrogen and progesterone receptors in breast cancer
por: D’Santos, Clive, et al.
Publicado: (2015)

Concordance between Immunohistochemistry and Microarray Gene Expression Profiling for Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Statuses in Breast Cancer Patients in Lebanon
por: Fakhri, Ghina B., et al.
Publicado: (2018)

The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification
por: Guan, Jun, et al.
Publicado: (2018)

Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer
por: Kalinina, Tatiana, et al.
Publicado: (2021)

Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
por: Hefti, Marco M, et al.
Publicado: (2013)

Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer
por: Schüler-Toprak, Susanne, et al.
Publicado: (2023)

Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer
por: Kavlashvili, Tamar, et al.
Publicado: (2016)

Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling
por: Singhal, Hari, et al.
Publicado: (2017)

Markers of Cellular Proliferation, Apoptosis, Estrogen/Progesterone Receptor Expression and Fibrosis in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids
por: Szydłowska, Iwona, et al.
Publicado: (2021)

Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer
por: Mehmeti, Meliha, et al.
Publicado: (2015)

Estrogen and Progesterone hormone receptor expression in oral cavity cancer
por: Grimm, Martin, et al.
Publicado: (2016)

Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha
por: Perkins, Meghan S., et al.
Publicado: (2022)

Estrogen receptor-α, progesterone receptor, and c-erbB/HER-family receptor mRNA detection and phenotype analysis in spontaneous canine models of breast cancer
por: Kabir, Farruk M. Lutful, et al.
Publicado: (2017)

Associations of Estrogen Receptor, Progesterone Receptor, Human Epidemic Growth Factor Receptor-2 and Ki-67 with Ultrasound Signs and Prognosis of Breast Cancer Patients
por: Zhao, Xingjuan, et al.
Publicado: (2021)

The impact of luteal phase support on endometrial estrogen and progesterone receptor expression: a randomized control trial
por: Brezina, Paul R, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2tm2lnlp9fjfpujeqhb0h9264d